Patrick J. LaRiccia

Patrick J. LaRiccia

Auto-generated profile, based on publicly available information

Patrick J. LaRiccia

Won Sook Chung Foundation

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Holistic Nursing Practice
Verified
Journal Article
Open access
MCMyung Kyu Chung
Myung Kyu Chung
PLPatrick J. LaRiccia
Patrick J. LaRiccia
Presented is the first reported case series of chronic neck and back pain associated with breast scars from breast surgery and successfully treated with an integrative medicine assessment and treatment approach, which included the assessment technique of autonomic response testing and the scar therapy technique of neural therapy. Implications for nursing practice are discussed.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

17 September 2022 in medRxiv
Verified
Preprint
Open access
PDF file
NHNoud van Helmond
Noud van Helmond
TBTracy L. Brobyn
Tracy L. Brobyn
PLPatrick J. LaRiccia
Patrick J. LaRiccia
TCTeresa Cafaro
Teresa Cafaro
KHKrystal Hunter
Krystal Hunter
MCMyung K. Chung
Myung K. Chung
Importance: Vitamin D supplementation has been shown to reduce the incidence of acute respiratory infections in populations at risk. The COVID-19 pandemic has highlighted the importance of preventing viral infections in healthcare workers. Objective: The aim of this study was to assess the hypothesis that vitamin D3 supplementation at 5000 IU daily reduces influenza-like illness (ILI), including COVID-19, in healthcare workers. Design: We conducted an open label, randomized clinical trial wherein a random group of healthcare workers was invited to receive 5000 IU daily vitamin D3 supplementation for nine months, while other random healthcare workers served as passive controls. All healthcare workers were required to self-monitor and report to employee health for COVID-19 testing when experiencing symptoms of ILI. COVID-19 test results were retrieved. Setting: The trial was conducted at a tertiary university hospital. Participants: Out of 7,600 healthcare workers, two groups of 4,708 and 2,892 subjects were pre-randomized to the vitamin D3 intervention and passive control groups, respectively. Out of 4,708 intervention subjects approached, 299 with no history of hypercalcemia or nephrolithiasis were enrolled. Subjects who completed at least 2 months of supplementation to ensure adequate vitamin D levels were included in the analysis (n=255). Intervention: Daily oral vitamin D3 gel capsules at 5000 IU for 9 months. Main Outcome and Measure: The primary analysis compared the incidence rate of all ILI, while secondary analyses examined incidence rates of COVID-19 ILI and non-COVID-19 ILI. Incidence rates were compared between the vitamin D and control groups. Results: Between October 2020 and November 2021, 255 healthcare workers (age 47±12 years, 199 women) completed at least two months of vitamin D3 supplementation. Five subjects were withdrawn due to adverse effects. The control group consisted of 2,827 workers. Vitamin D3 5000 IU supplementation was associated with lower risk of ILI (incidence rate difference: - 1.7×10 -4 /person-day, 95%-CI: -3.0×10 -4 to -3.3×10 -5 /person-day, P = 0.015) and a lower incidence rate for non-COVID-19 ILI (incidence rate difference: -1.3×10 -4 /person-day, 95%-CI - 2.5×10 -4 to -7.1×10 -6 /person-day, P = 0.038). COVID-19 ILI incidence was not statistically different (incidence rate difference: -4.2×10 -5 /person-day, 95%-CI: -10.0×10 -5 to 1.5×10 -5 /person-day, P = 0.152). An intention-to-treat analysis could not be performed due to low enrollment in the pre-randomized intervention group. Conclusion and Relevance: Daily supplementation with 5000 IU vitamin D3 reduces influenza-like illness in healthcare workers. Trial Registration: Clinicaltrials.gov , NCT04596657 Key Points: Question: Can 5,000 IU of daily vitamin D3 prevent influenza-like illness in healthcare workers? Findings: In this randomized controlled trial, 5,000 IU of once daily vitamin D3 over a 9-month period revealed that vitamin D3 supplementation was associated with a statistically significant lower risk of influenza-like illness (incidence rate difference -1.7 × 10 -4 / person-day, 95%-CI - 3.0 × 10 -4 to -3.3 × 10 -5 / person-day, P = 0.0147). Meaning: Daily supplementation with 5,000 IU vitamin D3 reduces influenza-like illness in healthcare workers.

1 January 2016 in Global Advances in Health and Medicine
Verified
Journal Article
Open access
DCDanielle Chung Couture
Danielle Chung Couture
MCMyung Kyu Chung
Myung Kyu Chung
PSPhillip Shinnick
Phillip Shinnick
JCJonathan Curzon
Jonathan Curzon
MMMark J. Mcclure
Mark J. Mcclure
PLPatrick J. Lariccia
Patrick J. Lariccia
Pediatric obsessive-compulsive disorder (OCD) is prevalent in 1% to 2% of the population. Emerging studies have correlated non-celiac gluten sensitivity with psychiatric conditions such as schizophrenia, depression, mania, and anxiety. This case study is the first reported case of OCD associated with non-celiac gluten sensitivity. The objectives of this case report are to (1) identify gluten sensitivity as a possible contributing factor to OCD in some patients; and (2) point out the possible benefit of an integrative medicine approach to the management of OCD in a patient with suboptimal benefit from a standard treatment regime. A 7-year-old male treated at a multi-physician integrative medicine practice in the United States had marked reduction of OCD symptoms and anxiety along with marked improvement of social behavior and school work after treatment consisting of gluten avoidance and other integrative medicine modalities. The patient's rapid response without side effects behooves the medical research community to further investigate the association of non-celiac gluten sensitivity and pediatric OCD.

1 January 2015 in EXPLORE
Verified
Journal Article
Open access
MCMyung Kyu Chung
Myung Kyu Chung
DCDanielle Chung
Danielle Chung
PLPatrick J. LaRiccia
Patrick J. LaRiccia
Chronic upper gastrointestinal (GI) symptoms of unclear etiology are frustrating to patients and physicians alike. The integrative medicine procedures of acupuncture and neural therapy may provide treatment options. Tongue piercing, which is prevalent in 5.6% of the adolescent population, may be a contributing factor in upper gastrointestinal symptoms. The objectives of the study were as follows: (1) To demonstrate the usefulness of an integrative medicine treatment approach in two cases of patients with chronic abdominal pain, nausea, and vomiting of unclear etiology who had failed standard medical management. (2) To identify scars from tongue piercings as a possible contributing factor in chronic upper GI symptoms of unclear etiology. Two retrospective case studies are presented of young adult females who were seen in a private multi-physician integrative medicine practice in the US. The patients were treated with neural therapy and acupuncture. The desired outcome was the cessation or reduction of the frequency of abdominal pain, nausea, and vomiting. Both patients had resolution of their symptoms. From this study, we have concluded the following: (1) Tongue scars from tongue rings may be causes of chronic upper gastrointestinal symptoms. (2) Neural therapy and acupuncture may be helpful in the treatment of chronic upper GI symptoms related to tongue scars.

1 July 2008 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
PLPatrick J. LaRiccia
Patrick J. LaRiccia
JFJohn T. Farrar
John T. Farrar
MSMary D. Sammel
Mary D. Sammel
JGJoseph J. Gallo
Joseph J. Gallo
Objective: To determine the efficacy of the food supplement OPC Factor™ to increase energy levels in healthy adults aged 45 to 65. Design: Randomized, placebo-controlled, triple-blind crossover study. Subjects: Twenty-five (25) healthy adults recruited from the University of Pennsylvania Health System. Interventions: OPC Factor,™ (AlivenLabs, Lebanon, TN) a food supplement that contains oligomeric proanthocyanidins from grape seeds and pine bark along with other nutrient supplements including vitamins and minerals, was in the form of an effervescent powder. The placebo was similar in appearance and taste. Outcome measures: Five outcome measurements were performed: (1) Energy subscale scores of the Activation–Deactivation Adjective Check List (AD ACL); (2) One (1) global question of percent energy change (Global Energy Percent Change); (3) One (1) global question of energy change measured on a Likert scale (Global Energy Scale Change); 4. One (1) global question of percent overall status change (Global Overall Status Percent Change); and (5) One (1) global question of overall status change measured on a Likert scale (Global Overall Status Scale Change). Results: There were no carryover/period effects in the groups randomized to Placebo/Active Product sequence versus Active Product/Placebo sequence. Examination of the AD ACL Energy subscale scores for the Active Product versus Placebo comparison revealed no significant difference in the intention-to-treat (IT) analysis and the treatment received (TR) analysis. However, Global Energy Percent Change (p = 0.06) and Global Energy Scale Change (p = 0.09) both closely approached conventional levels of statistical significance for the active product in the IT analysis. Global Energy Percent Change (p = 0.05) and Global Energy Scale Change (p = 0.04) reached statistical significance in the TR analysis. A cumulative percent responders analysis graph indicated greater response rates for the active product. Conclusions: OPC Factor™ may increase energy levels in healthy adults aged 45–65 years. A larger study is recommended. Clinical Trials.gov identifier: NCT03318019

26 September 2023 in medRxiv
Verified
Preprint
Open access
PDF file
PLPatrick J. LaRiccia
Patrick J. LaRiccia
TCTeresa Cafaro
Teresa Cafaro
DJDibato John
Dibato John
NHNoud van Helmond
Noud van Helmond
LMLudmil Mitrev
Ludmil Mitrev
MCMyung K. Chung
Myung K. Chung
Vitamin D insufficiency has been linked to multiple conditions including bone disease, respiratory disease, cardiovascular disease, diabetes, and cancer. Observational studies indicate lower healthcare costs and healthcare utilization with sufficient vitamin D levels. The secondary aims of our previously published pragmatic clinical trial of vitamin D3 supplementation were comparisons of healthcare costs and healthcare utilization. Comparisons were made between the vitamin D3 at 5000 IU supplementation group and a non-supplemented control group. Costs of care between the groups were not statistically different. Vitamin D3 supplementation reduced healthcare utilization in four major categories: hospitalizations for any reason (rate difference: -0.19 per 1000 person-days, 95%-CI: -0.21 to -0.17 per 1000 person-days, p < 0.0001); ICU admissions for any reason (rate difference: -0.06 per 1000 person-days, 95%-CI: -0.08 to -0.04 per 1000 person-days, p < 0.0001); emergency room visits for any reason (rate difference: -0.26 per 1000 person-days, 95%-CI: -0.46 to -0.05 per 1000 person-days, p = 0.0131; and hospitalizations due to Covid-19 (rate difference: -8.47X10 −3 per 1000 person-days, 95%-CI: -0.02 to -1.05X10 −3 per 1000 person-days, p = 0.0253). Appropriately powered studies of longer duration are recommended for replication of these utilization findings and analysis of cost differences.